Neurologists from multiple clinics presented data at AAIC on Leqembi's use, shedding light on its safety and efficacy outside ...

The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.

Trontinemab is a formulation of Roche's failed gantenerumab but now paired with the company's Brainshuttle technology to ...

The FDA investigated the death of a boy in Brazil on Elevidys and concluded it was unrelated to the treatment.

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended regulators approve Servier's IDH1/2 inhibitor Voranigo (vorasidenib) as a treatment for ...